Letters to the Editor
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis
P. Delvino1, E. Bozzalla-Cassione2, A. Biglia3, V.S. Quadrelli4, A. Bartoletti5, C. Montecucco6, S. Monti7
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, and PhD in Experimental Medicine, University of Pavia, Italy. paolo.delvino01@universitadipavia.it
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
- Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
CER14912
2022 Vol.40, N°4
PI 0853
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 34528506 [PubMed]
Received: 18/06/2021
Accepted : 23/07/2021
In Press: 16/09/2021
Published: 04/05/2022
